In timing with the BIO International Convention, JSR Life Sciences has announced it is bringing Selexis under the KBI banner, while RoslinCT is fully absorbing CDMO Lykan Bioscience. Boston plays host to BIO this week but ahead of the main event, inboxes have already been filled with industry players looking to shout their news from the BCEC’s rooftops. While many of these can be ignored – editorial aside, just because you think its interesting it doesn’t mean we do –…
Details are sparse, but the investment will include facility and equipment improvements and the addition of 60 full-time positions at 3M manufacturing facilities in Europe. Industrial conglomerate 3M offers, among its many products, depth filters for cell culture clarification used in biomanufacturing. To support what it terms as “a fast-growing area of health care which is bringing breakthrough therapies to patients,” the firm is expanding its European network through a $146 million investment. The cash injection will speed up development…
After leading the funding round, Charles River Laboratories will implement its biologics testing lab RightSource at Wheeler Bio’s biologics drug substance plant in Oklahoma. Charles River Laboratories (CRL) already has a connection with contract development manufacturing organization (CDMO) Wheeler, having led its series A financing round in October 2022 to help expand a drug substance facility in Oklahoma. Now CRL has decided to set up shop inside the facility. CRL will deploy and operate platform-based satellite lab RightSource at the CDMO’s…
Rentschler Biopharma will carry out adeno-associated virus (AAV) process development activity to scale-up manufacturing of Ikarovec’s lead candidate from its site in Stevenage, UK. Under the terms of the deal, of which financial details have not been disclosed, contract development and manufacturing organization (CDMO) Rentschler will use its advanced therapy medicinal product (ATMP) site in Stevenage to support the bioprocess advancement of AAV material for pre-clinical testing of Ikarovec’s gene therapy treatment for geographic atrophy. “We are delighted to collaborate…